A detailed history of Redwood Investment Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Redwood Investment Management, LLC holds 1,205 shares of LLY stock, worth $958,782. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,205
Previous 4,943 75.62%
Holding current value
$958,782
Previous $4.28 Million 75.05%
% of portfolio
0.09%
Previous 0.37%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $2.89 Million - $3.59 Million
-3,738 Reduced 75.62%
1,205 $1.07 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $71,037 - $89,085
98 Added 2.02%
4,943 $4.28 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $772,821 - $1.03 Million
1,305 Added 36.86%
4,845 $3.77 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $1.48 Million - $1.75 Million
-2,824 Reduced 44.37%
3,540 $2.06 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $1.69 Million - $2.34 Million
3,898 Added 158.07%
6,364 $3.42 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $225,525 - $301,554
-643 Reduced 20.68%
2,466 $1.16 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $120,835 - $141,914
-389 Reduced 11.12%
3,109 $1.07 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $635,060 - $723,717
2,142 Added 157.96%
3,498 $1.13 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $54,073 - $63,490
194 Added 16.7%
1,356 $440,000
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $69,468 - $86,331
-296 Reduced 20.3%
1,162 $333,000
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $327,831 - $406,840
1,458 New
1,458 $403,000
Q3 2020

Nov 16, 2020

SELL
$146.22 - $169.13 $197,250 - $228,156
-1,349 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $184,030 - $221,478
1,349 New
1,349 $221,000
Q1 2020

May 13, 2020

SELL
$119.05 - $147.35 $973,590 - $1.21 Million
-8,178 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $26,195 - $32,445
245 Added 3.09%
8,178 $1.08 Million
Q3 2019

Nov 18, 2019

BUY
$106.79 - $116.16 $847,165 - $921,497
7,933 New
7,933 $887,000
Q2 2019

Aug 15, 2019

SELL
$110.79 - $129.32 $647,345 - $755,616
-5,843 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$110.79 - $129.32 $647,345 - $755,616
5,843 New
5,843 $669,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Redwood Investment Management, LLC Portfolio

Follow Redwood Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redwood Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redwood Investment Management, LLC with notifications on news.